| 体外研究: |
ML-792 (0.0007-5 μM; 4 hours) inhibits SAE and SUMO-pathway activities in HCT116 cells. ML-792 (0.001-10 μM; 72 hours ) inhibits cell proliferation and decreases cancer cell viability in MDA-MB-468, MDA-MB-231, HCT116, Colo-205, and A375. Cell Viability Assay Cell Line: Human breast cancer cells MDA-MB-468 and MDA-MB-231; human colon carcinoma cells HCT116 and Colo-205; human melanoma cell line A375 Concentration: 0.001, 0.01, 0.1, 1, 10 μM Incubation Time: 72 hours Result: Demonstrated a dose-dependent viability effect with EC50 values of 0.06 μM in MDA-MB-468 cells to 0.45 μM in A375 cells. Western Blot Analysis[1] Cell Line: HCT116 cells Concentration: 0, 0.0007, 0.002, 0.007, 0.02, 0.06, 0.19, 0.56, 1.7, 5 μM Incubation Time: 4 hours Result: Revealed a dose-dependent decrease in the SAE and UBC9 thioester levels. |